Variables | Univariate | Multivariate* | Multivariate† | ||||||
HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | |
Gender (female vs male) | 1.676 | 0.757–3.707 | 0.203 | ||||||
Age (<70 vs ≥70) | 1.770 | 0.997–3.143 | 0.051 | ||||||
Smoking status (non-smoker vs smoker) | 1.693 | 0.990–2.896 | 0.054 | ||||||
Metastasis (negative vs positive) | 0.877 | 0.214–3.605 | 0.856 | ||||||
SCLC staging (I–II vs III) | 2.111 | 1.243–3.586 | 0.006 | 1.951 | 1.146–3.322 | 0.014 | 1.836 | 1.077–3.131 | 0.026 |
Gal-9 on tumor cells (negative vs positive) | 1.108 | 0.636–1.932 | 0.717 | ||||||
Gal-9 on TILs (negative vs positive) | 0.399 | 0.195–0.818 | 0.012 | 0.436 | 0.212–0.897 | 0.024 | |||
Risk score (low vs high) | 3.874 | 1.541–9.741 | 0.004 | 3.424 | 1.351–8.676 | 0.009 |
Statistically significant data were marked with bold and underline.
*Multivariate Cox regression analysis beyond risk score.
†Multivariate Cox regression analysis that included risk score.
Gal-9, galectin-9; SCLC, small cell lung cancer; TILs, tumor-infiltrating lymphocytes.